<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ExpressMedCare</title>
	<atom:link href="http://expressmedcare.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://expressmedcare.com</link>
	<description>Walk In Clinics Silver Spring &#124; Walk In Clinics Silver Spring Metro</description>
	<lastBuildDate>Tue, 21 Feb 2012 22:10:37 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Blurry line in diagnosing early Alzheimer&#039;s: study</title>
		<link>http://expressmedcare.com/blurry-line-in-diagnosing-early-alzheimers-study/</link>
		<comments>http://expressmedcare.com/blurry-line-in-diagnosing-early-alzheimers-study/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 22:23:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[medical news]]></category>

		<guid isPermaLink="false">http://xpressmedcare.com/blurry-line-in-diagnosing-early-alzheimers-study/</guid>
		<description><![CDATA[By Genevra Pittman NEW YORK &#124; Mon Feb 6, 2012 5:23pm EST NEW YORK (Reuters Health) &#8211; The revised definition of a brain condition called mild cognitive impairment means that many people now considered to have mild or early Alzheimer&#8217;s disease could easily be given that diagnosis instead, suggests a new study. Mild cognitive impairment &#8230; <a href="http://expressmedcare.com/blurry-line-in-diagnosing-early-alzheimers-study/">more</a>]]></description>
		<wfw:commentRss>http://expressmedcare.com/blurry-line-in-diagnosing-early-alzheimers-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ovarian cancer screening popular despite guidelines</title>
		<link>http://expressmedcare.com/ovarian-cancer-screening-popular-despite-guidelines/</link>
		<comments>http://expressmedcare.com/ovarian-cancer-screening-popular-despite-guidelines/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 22:20:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[medical news]]></category>

		<guid isPermaLink="false">http://xpressmedcare.com/ovarian-cancer-screening-popular-despite-guidelines/</guid>
		<description><![CDATA[By Frederik Joelving NEW YORK &#124; Mon Feb 6, 2012 5:20pm EST NEW YORK (Reuters Health) &#8211; Despite expert guidelines and scientific evidence to the contrary, a third of U.S. primary care physicians believe ovarian cancer screening is effective and many would offer it to patients, according to a new survey. Although the results don&#8217;t &#8230; <a href="http://expressmedcare.com/ovarian-cancer-screening-popular-despite-guidelines/">more</a>]]></description>
		<wfw:commentRss>http://expressmedcare.com/ovarian-cancer-screening-popular-despite-guidelines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diet supplements recalled on unlabeled drug worries</title>
		<link>http://expressmedcare.com/diet-supplements-recalled-on-unlabeled-drug-worries/</link>
		<comments>http://expressmedcare.com/diet-supplements-recalled-on-unlabeled-drug-worries/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 21:50:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[medical news]]></category>

		<guid isPermaLink="false">http://xpressmedcare.com/diet-supplements-recalled-on-unlabeled-drug-worries/</guid>
		<description><![CDATA[WASHINGTON &#124; Mon Feb 6, 2012 4:50pm EST WASHINGTON (Reuters) &#8211; Healthy People Co is recalling 15 lots of seven different dietary supplements because they contain appetite suppressants or a drug for male erectile dysfunction, the Long Beach, California, company said. The seven brands of supplements were sold at the company&#8217;s store at 13105 Ramona &#8230; <a href="http://expressmedcare.com/diet-supplements-recalled-on-unlabeled-drug-worries/">more</a>]]></description>
		<wfw:commentRss>http://expressmedcare.com/diet-supplements-recalled-on-unlabeled-drug-worries/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fitness and &quot;fatness&quot; both matter to the heart</title>
		<link>http://expressmedcare.com/fitness-and-fatness-both-matter-to-the-heart/</link>
		<comments>http://expressmedcare.com/fitness-and-fatness-both-matter-to-the-heart/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 21:19:38 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[medical news]]></category>

		<guid isPermaLink="false">http://xpressmedcare.com/fitness-and-fatness-both-matter-to-the-heart/</guid>
		<description><![CDATA[By Amy Norton NEW YORK &#124; Mon Feb 6, 2012 4:19pm EST NEW YORK (Reuters Health) &#8211; Losing fitness or packing on fat with age each can be bad for the heart &#8212; but avoiding either one of those fates may protect the ticker, a study published Monday suggests. U.S. researchers found that of more &#8230; <a href="http://expressmedcare.com/fitness-and-fatness-both-matter-to-the-heart/">more</a>]]></description>
		<wfw:commentRss>http://expressmedcare.com/fitness-and-fatness-both-matter-to-the-heart/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Male smokers lose brain function faster as they age</title>
		<link>http://expressmedcare.com/male-smokers-lose-brain-function-faster-as-they-age/</link>
		<comments>http://expressmedcare.com/male-smokers-lose-brain-function-faster-as-they-age/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 21:15:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[medical news]]></category>

		<guid isPermaLink="false">http://xpressmedcare.com/male-smokers-lose-brain-function-faster-as-they-age/</guid>
		<description><![CDATA[By Kate Kelland LONDON &#124; Mon Feb 6, 2012 4:15pm EST LONDON (Reuters) &#8211; Men who smoke suffer a more rapid decline in brain function as they age than their non-smoking counterparts, with their cognitive decline as rapid as someone 10 years older but who shuns tobacco, scientists said on Monday. In a large, long-term &#8230; <a href="http://expressmedcare.com/male-smokers-lose-brain-function-faster-as-they-age/">more</a>]]></description>
		<wfw:commentRss>http://expressmedcare.com/male-smokers-lose-brain-function-faster-as-they-age/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Skepticism grows around Medco/Express Scripts deal</title>
		<link>http://expressmedcare.com/skepticism-grows-around-medcoexpress-scripts-deal/</link>
		<comments>http://expressmedcare.com/skepticism-grows-around-medcoexpress-scripts-deal/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 19:54:59 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[medical news]]></category>

		<guid isPermaLink="false">http://xpressmedcare.com/skepticism-grows-around-medcoexpress-scripts-deal/</guid>
		<description><![CDATA[By Diane Bartz WASHINGTON &#124; Mon Feb 6, 2012 2:54pm EST WASHINGTON (Reuters) &#8211; Objections to Express Scripts&#8217; $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as U.S. antitrust regulators weigh whether they have enough evidence to stop the megamerger. The Food Marketing Institute, which represents the biggest grocery &#8230; <a href="http://expressmedcare.com/skepticism-grows-around-medcoexpress-scripts-deal/">more</a>]]></description>
		<wfw:commentRss>http://expressmedcare.com/skepticism-grows-around-medcoexpress-scripts-deal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>&quot;Malaria cure&quot; claim sparks Vienna probe</title>
		<link>http://expressmedcare.com/malaria-cure-claim-sparks-vienna-probe/</link>
		<comments>http://expressmedcare.com/malaria-cure-claim-sparks-vienna-probe/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 18:08:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[medical news]]></category>

		<guid isPermaLink="false">http://xpressmedcare.com/malaria-cure-claim-sparks-vienna-probe/</guid>
		<description><![CDATA[By Michael Shields VIENNA &#124; Mon Feb 6, 2012 1:08pm EST VIENNA (Reuters) &#8211; A Vienna hospital is searching for long-retired staff who might hold clues to a man&#8217;s claim that he was deliberately infected with malaria when he was a psychiatric patient nearly half a century ago. The case shed fresh light on an &#8230; <a href="http://expressmedcare.com/malaria-cure-claim-sparks-vienna-probe/">more</a>]]></description>
		<wfw:commentRss>http://expressmedcare.com/malaria-cure-claim-sparks-vienna-probe/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Marathoners who go the distance 100 times or more</title>
		<link>http://expressmedcare.com/marathoners-who-go-the-distance-100-times-or-more/</link>
		<comments>http://expressmedcare.com/marathoners-who-go-the-distance-100-times-or-more/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 16:46:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[medical news]]></category>

		<guid isPermaLink="false">http://xpressmedcare.com/marathoners-who-go-the-distance-100-times-or-more/</guid>
		<description><![CDATA[By Dorene Internicola NEW YORK &#124; Mon Feb 6, 2012 11:46am EST NEW YORK (Reuters) &#8211; For most people running one marathon is a daunting prospect but research scientist Leslie Miller belongs to group of runners who have completed 100 or more marathons, many of them just for the fun of it. &#8220;It&#8217;s my hobby,&#8221; &#8230; <a href="http://expressmedcare.com/marathoners-who-go-the-distance-100-times-or-more/">more</a>]]></description>
		<wfw:commentRss>http://expressmedcare.com/marathoners-who-go-the-distance-100-times-or-more/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Orexigen, FDA agree on trial design for obesity drug</title>
		<link>http://expressmedcare.com/orexigen-fda-agree-on-trial-design-for-obesity-drug/</link>
		<comments>http://expressmedcare.com/orexigen-fda-agree-on-trial-design-for-obesity-drug/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 15:28:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[medical news]]></category>

		<guid isPermaLink="false">http://xpressmedcare.com/orexigen-fda-agree-on-trial-design-for-obesity-drug/</guid>
		<description><![CDATA[Mon Feb 6, 2012 10:28am EST (Reuters) &#8211; Orexigen Therapeutics Inc said it reached an agreement with U.S. health regulators on the design of a heart-safety trial required for the approval of its experimental obesity drug. The biopharmaceutical company plans to enroll about 10,000 patients in the placebo-controlled trial for demonstrating that the drug Contrave &#8230; <a href="http://expressmedcare.com/orexigen-fda-agree-on-trial-design-for-obesity-drug/">more</a>]]></description>
		<wfw:commentRss>http://expressmedcare.com/orexigen-fda-agree-on-trial-design-for-obesity-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA staff unsure about new use for Amgen&#039;s Xgeva</title>
		<link>http://expressmedcare.com/fda-staff-unsure-about-new-use-for-amgens-xgeva/</link>
		<comments>http://expressmedcare.com/fda-staff-unsure-about-new-use-for-amgens-xgeva/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 15:18:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[medical news]]></category>

		<guid isPermaLink="false">http://xpressmedcare.com/fda-staff-unsure-about-new-use-for-amgens-xgeva/</guid>
		<description><![CDATA[By Anna Yukhananov WASHINGTON &#124; Mon Feb 6, 2012 10:18am EST WASHINGTON (Reuters) &#8211; Reviewers from the U.S. Food and Drug Administration said on Monday that they were not sure whether Amgen Inc&#8217;s Xgeva bone drug should be approved for a wider use of delaying the spread of cancer to the bone. The injectable drug &#8230; <a href="http://expressmedcare.com/fda-staff-unsure-about-new-use-for-amgens-xgeva/">more</a>]]></description>
		<wfw:commentRss>http://expressmedcare.com/fda-staff-unsure-about-new-use-for-amgens-xgeva/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

